Intranasal Fasedienol Appears to Be Safe, Effective for Social Anxiety Disorder
Fasedienol (PH94B) is a first-in-class, rapid-onset investigational pherine nasal spray.
Fasedienol (PH94B) is a first-in-class, rapid-onset investigational pherine nasal spray.
ABBV-951 is a solution of levodopa and carbidopa prodrugs for continuous subcutaneous delivery.
Donanemab is an antibody therapy that targets a modified form of deposited amyloid-β peptide called N3pG.
Increased demand for ibuprofen oral suspension products due to a surge in 3 circulating viruses prompted the Agency to issue compounding guidance.
Rezafungin is an investigational echinocandin antifungal that is administered once weekly.
Recent data show that the product is unlikely to be active against currently circulating SARS-CoV-2 variants.
It was originally approved in 2019 for the treatment of chronic pain.
The approval was based on data from the KEYNOTE-091 trial.
Enjaymo is an immunoglobulin G subclass 4 monoclonal antibody.
As a noncovalent inhibitor of BTK, pirtobrutinib is able to reestablish BTK inhibition in patients previously treated with covalent BTK inhibitors.